Treatment options for cystic fibrosis: case study and panel discussion.
Kuhn
Robert J
RJ
Flume
Patrick A
PA
D000280:Administration, Inhalation; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D018942:Macrolides; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D012129:Respiratory Function Tests; D014031:Tobramycin / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D018942:Macrolides; D014031:Tobramycin